These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1438430

  • 1. A simple method to detect immature hemopoietic progenitors after in vitro treatment with ASTA-Z 7654.
    Lamana M, Gonzalez R, Camara R, Steegmann JL, Fernandez-Rañada JM.
    Prog Clin Biol Res; 1992; 377():35-9. PubMed ID: 1438430
    [No Abstract] [Full Text] [Related]

  • 2. [A simple method for detecting immature precursors after in vitro bone marrow treatment with ASTA-Z 7654].
    Lamana M, Fernández-Rañada JM.
    Sangre (Barc); 1991 Dec; 36(6):501-3. PubMed ID: 1812583
    [Abstract] [Full Text] [Related]

  • 3. Effect of mafosfamide (ASTA-Z-7654) on the clonogenic cells in precursor-B acute lymphoblastic leukaemia: significance for ex vivo purging of bone marrow for autologous transplantation.
    Makrynikola V, Kabral A, Bradstock KF.
    Bone Marrow Transplant; 1991 Nov; 8(5):351-5. PubMed ID: 1768969
    [Abstract] [Full Text] [Related]

  • 4. In vitro purging of bone marrow with mafosfamide synergizes with in vivo chemotherapy to delay the hematological recovery in a murine model of autologous bone marrow transplantation.
    Lopez M, Mary JY, Sainteny F.
    Exp Hematol; 1993 Feb; 21(2):311-8. PubMed ID: 8425567
    [Abstract] [Full Text] [Related]

  • 5. Comparative in vitro effects of cyclophosphamide derivatives on murine bone marrow-derived stromal and hemopoietic progenitor cell classes.
    de Jong JP, Nikkels PG, Brockbank KG, Ploemacher RE, Voerman JS.
    Cancer Res; 1985 Sep; 45(9):4001-5. PubMed ID: 3896474
    [Abstract] [Full Text] [Related]

  • 6. Pharmacologic bone marrow purging: is there any place for etoposide? In vitro comparison with mafosfamide.
    Olivieri A, Poloni A, Montanari M, Cantori I, Corvatta L, Masia MC, Curzi L, Mancini S, Leoni P.
    J Hematother; 1997 Apr; 6(2):137-44. PubMed ID: 9131443
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the protection of murine bone marrow stem cells by WR-2721 during in vitro treatment with mafosfamide.
    Jiang R, Bony V, Lopez M.
    Prog Clin Biol Res; 1994 Apr; 389():23-9. PubMed ID: 7700906
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of a combined purging with mafosfamide and hyperthermia on murine haemopoietic stem cells and leukaemogenic cells.
    Gidáli J, Fehér I.
    Bone Marrow Transplant; 1992 Dec; 10(6):479-83. PubMed ID: 1490197
    [Abstract] [Full Text] [Related]

  • 12. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
    Ratajczak MZ, Ratajczak J, Kuczynski W, Light B, Lusk EJ, Gewirtz AM.
    Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
    [Abstract] [Full Text] [Related]

  • 13. Collagen gel cultures for detection of spared hematopoietic progenitors in Asta Z 7557 purged human marrows.
    Praloran V, Dobo I, Garand R, Klausman M, Naud MF, Milpied N, Harousseau JL.
    Leukemia; 1990 Apr; 4(4):282-6. PubMed ID: 2366583
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of purging clonogenic leukemia cells using ether lipid and hyperthermia for autologous bone marrow transplantation.
    Min WS, Park HM, Han CH, Park JW, Kim CC, Kim DJ.
    Prog Clin Biol Res; 1992 Apr; 377():87-95. PubMed ID: 1438449
    [No Abstract] [Full Text] [Related]

  • 15. In vitro effects of Ilmofosine on acute lymphoblastic leukemia cells and on normal hemopoietic cells.
    Skala JP, Rogers PC, Chan KW, Khangura SS, Rodriguez WC.
    Prog Clin Biol Res; 1992 Apr; 377():63-9. PubMed ID: 1438445
    [No Abstract] [Full Text] [Related]

  • 16. Difference in kinetics of hematopoietic reconstitution between ALL and ANLL after autologous bone marrow transplantation with marrow treated in vitro with mafosfamide (ASTA Z 7557).
    Douay L, Laporte JP, Mary JY, Lopez M, Lemonnier MP, Stachowiak J, Benitez O, Deloux J, Najman A, Salmon C.
    Bone Marrow Transplant; 1987 Jun; 2(1):33-43. PubMed ID: 3332155
    [Abstract] [Full Text] [Related]

  • 17. Effects of mafosfamide on the clonogenic cells in precursor B acute lymphoblastic leukemia: significance for ex vivo purging of bone marrow.
    Kramer B, Makrynikola V, Bradstock K.
    Prog Clin Biol Res; 1992 Jun; 377():41-7. PubMed ID: 1438438
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of a combined treatment with ASTA-Z 7654 and VP16-213 in vitro in eradicating clonogenic tumor cells from human bone marrow.
    De Fabritiis P, Pulsoni A, Sandrelli A, Simone F, Amadori S, Meloni G, Mandelli F.
    Bone Marrow Transplant; 1987 Oct; 2(3):287-98. PubMed ID: 3502785
    [Abstract] [Full Text] [Related]

  • 19. Preclinical studies of the combination of mafosfamide (Asta-Z 7654) and etoposide (VP-16-213) for purging leukemic autologous marrow.
    Tamayo E, Hervé P.
    Exp Hematol; 1988 Feb; 16(2):97-101. PubMed ID: 3276544
    [Abstract] [Full Text] [Related]

  • 20. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
    Carlo-Stella C, Mangoni L, Piovani G, Almici C, Garau D, Caramatti C, Rizzoli V.
    Bone Marrow Transplant; 1991 Oct; 8(4):265-73. PubMed ID: 1756324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.